Royston, UK (27 January 2010) - This year at Screening Europe 2010, TTP LabTech will be sharing its in-house expertise and technical advice with exhibition delegates in order to further improve current high content screening techniques and workflows. On 11^th February, TTP LabTech will be offering a free workshop entitled "The Identification of novel cancer targets using a rapid, high-content, genome wide RNAi screen". Based on the Acumen platform, this workshop will describe how information identifying high quality hits can be accessed quickly, easily and cost effectively either by in-house data generation or via an outsourced service.  

In addition, Gaetan Touyer, Head of Screening Group, Vitry Research Center at Sanofi Aventis will present a study of five screening assays, including cell-based protein-protein interaction, homogeneous cell receptor ligand binding and cell cycle analysis at 11.45am on the 12^th February. The talk explores his experiences of integrating the Acumen ^eX3 (TTP LabTech) microplate cytometer into an HTS platform to achieve a screening throughput of tens of thousands of wells per day using a complex yet controlled process with multiple experimental steps. 

Visitors to the TTP LabTech stand #12, will also be able to find out more about the new high content screening service now on offer. Based on the industry-proven Acumen platform, this service offers a highly flexible approach to cell-based screening, providing high-throughput, content-rich and highly multiplexed data for applications such as target identification, primary screening and preclinical toxicology.  

For more information about the workshop, please visit www.selectbiosciences.com/conferences/SE2010/TTP_Workshop.aspx. For more information about TTP LabTech, the Acumen microplate cytometer and contract screening services, please come to Stand 12 or visit http://www.ttplabtech.com/.